Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
14%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
BBP
70
HOLDINGS
21%
ALSO IN CANC
CANC
54
HOLDINGS
24%
ALSO IN BBP
SECTOR DRIFT (BBP minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ZAI LAB LTD. UNSPONSORED ADR | 1.5% | 1.8% | 1.5% |
 |
BRIDGEBIO PHARMA, INC. | 1.4% | 2.8% | 1.4% |
|
EXELIXIS INC | 1.4% | 2.9% | 1.4% |
|
AMGEN INC | 1.4% | 2.6% | 1.4% |
|
HALOZYME THERAPEUTICS INC | 1.4% | 1.3% | 1.3% |
BBP Overweight Relative to CANC
|
MODERNA, INC. | 1.9% |
|
OMEROS CORP | 1.7% |
|
AGIOS PHARMACEUTICALS INC | 1.7% |
|
SAREPTA THERAPEUTICS INC | 1.6% |
|
ULTRAGENYX PHARMACEUTICAL IN | 1.6% |
|
CYTOKINETICS INC | 1.6% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 1.6% |
|
RHYTHM PHARMACEUTICALS, INC. | 1.6% |
|
KURA ONCOLOGY, INC. | 1.6% |
|
GERON CORP | 1.6% |
BBP Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -6.6% |
|
ELI LILLY & CO | -5.1% |
|
COGENT BIOSCIENCES INC | -4.4% |
 |
NOVARTIS AG | -4.2% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -4.2% |
|
MERCK & CO. INC. | -3.5% |
|
IMMUNOME, INC. | -3.4% |
|
BRISTOL-MYERS SQUIBB CO | -3.4% |
|
NUVALENT, INC. CLASS A | -3.3% |
 |
ASTRAZENECA PLC | -3.1% |